Greenpro Capital Corp. current report, 09 October 2020

Business Context and Reporting Period

Company: Greenpro Capital Corp.
Filing Type: Form 8-K (Current Report)
Date of Report: October 9, 2020
Reporting Period: Event date October 9, 2020; Signed October 16, 2020
Business Context: The Company, incorporated in Nevada and headquartered in Kuala Lumpur, Malaysia, reported the entry into material definitive agreements regarding a private placement of equity securities.

Key Financial Metrics

This filing details a specific capital raise event rather than periodic financial performance. Key metrics related to the transaction include:

  • Shares Issued: 195,455 shares of common stock.
  • Price Per Share: $1.10.
  • Aggregate Gross Proceeds: $215,000.
  • Use of Proceeds: Working capital and general corporate purposes.

Note: The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity positions as this is a transaction-specific report, not a financial statement.

Material Changes

The primary material change reported is the increase in outstanding common stock and cash assets resulting from the private placement. The Company issued 195,455 shares to accredited investors, raising $215,000 in gross proceeds. No comparative period data is provided in this document to assess changes in operating metrics.

Guidance, Outlook, and Risks

Management Commentary: Management intends to utilize the proceeds from the private placement for working capital and general corporate purposes.
Regulatory Status: The sale of shares was conducted as a private placement exempt from registration under Section 4(2) of, and/or Rule 506 under Regulation D, or Regulation S of the Securities Act of 1933.
Risks and Contingencies: The filing does not explicitly list new risks or contingencies beyond the standard terms of the subscription agreement, which is attached as an exhibit.

Investor Verification Checklist

  • Verify the total number of shares outstanding post-transaction to assess dilution impact.
  • Confirm the identity of the accredited investors involved in the $215,000 placement.
  • Review the attached Exhibit 10.1 (Form of Subscription Agreement) for specific terms, vesting schedules, or rights associated with the new shares.
  • Monitor subsequent filings to track the actual utilization of proceeds for working capital.